US2001056069A1PendingUtilityA1

Use of collagen for the treatment of degenerative articular processes

37
Priority: Jul 31, 1991Filed: Oct 5, 2000Published: Dec 27, 2001
Est. expiryJul 31, 2011(expired)· nominal 20-yr term from priority
Inventors:Edwin Klaus
A61P 43/00A61P 29/00A61K 38/39
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of collagen for the production of a drug for the treatment of degenerative articular processes. An injection suspension is preferably produced, which contains collagen and possibly a local anaesthetic. This injection suspension is applied into the affected joints by means of an injection.

Claims

exact text as granted — not AI-modified
1 . Use of collagen for producing a drug for the treatment of arthropathies, characterized in that the collagen is contained in an injection suspension.  
     
     
         2 . Use according to    claim 1   , characterized in that the amount of the collagen contained in the injection suspension is about 20 to 50 mg/ml.  
     
     
         3 . Use according to any of claims  1  or  2 , characterized in that a local anaesthetic is also contained.  
     
     
         4 . Use according to    claim 3   , characterized in that the amount of the local anaesthetic contained in the injection suspension is 1 to 5 mg/ml.  
     
     
         5 . Use according to any of    claims 1    to    4   , characterized in that the collagen contained in the drug is collagen from bovine skin.

Join the waitlist — get patent alerts

Track US2001056069A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.